Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2)
<p>Abstract</p> <p>Background</p> <p>Enhancer of zeste homologue 2 (EZH2) is a polycomb group (PcG) family protein. Acting as a histone methyltransferase it plays crucial roles in maintaining epigenetic stem cell signature, while its deregulation leads to tumor developm...
Main Authors: | Changchien Yi-Che, Tátrai Péter, Papp Gergő, Sápi Johanna, Fónyad László, Szendrői Miklós, Pápai Zsuzsanna, Sápi Zoltán |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-10-01
|
Series: | Journal of Translational Medicine |
Subjects: | |
Online Access: | http://www.translational-medicine.com/content/10/1/216 |
Similar Items
-
Correlation between DNA ploidy, metaphase high-resolution comparative genomic hybridization results and clinical outcome of synovial sarcoma
by: Papp Gergő, et al.
Published: (2011-11-01) -
EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves’ ophthalmopathy
by: Sopita Visamol, et al.
Published: (2024-04-01) -
Treating human cancer by targeting EZH2
by: Mengfei Xu, et al.
Published: (2025-05-01) -
Divergent Effects of EZH1 and EZH2 Protein Expression on the Prognosis of Patients with T-Cell Lymphomas
by: Franziska Lea Schümann, et al.
Published: (2021-12-01) -
The Role of the Histone Methyltransferase EZH2 in Liver Inflammation and Fibrosis in STAM NASH Mice
by: Seul Lee, et al.
Published: (2020-05-01)